Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Painless
Recent news which mentions Painless
OncoBeta introduces Rhenium-SCT for non-melanoma skin cancer patients at Hospital Universitario 12 de Octubre
June 20, 2024
Tags
Non/invasive
Munich
Skin Cancer Treatment
From
PRLog
Latest research shows Australians still not getting annual skin checks with a Health Professional
March 01, 2023
Tags
Beauty
Painless
OncoBeta GmbH
From
PRLog
London skin cancer patients undergo first treatments with OncoBeta's Rhenium-SCT as part of the EPIC-Skin study
September 27, 2022
Tags
London City
Rhenium/SCT
NMSC therapy
From
PRLog
German skin cancer patients join the EPIC-Skin study
July 28, 2022
Tags
Painless
Beauty
OncoBeta GmbH
From
PRLog
Sydney skin cancer patients join the EPIC-Skin study as they undergo first treatments with OncoBeta's Rhenium-SCT
April 13, 2022
Tags
Munich
Rhenium/188
Non/invasive
From
PRLog
EPIC-Skin study welcomes world-first skin cancer patients treated with OncoBeta's Rhenium-SCT
March 10, 2022
Tags
Bavaria
Investment
Munich
From
PRLog
OncoBeta receives ethics approval for EPIC-Skin study to evaluate Rhenium-SCT in Australia
December 21, 2021
Tags
Sydney
Beauty
Painless
From
PRLog
South African non-melanoma skin cancer patients now have greater access in the area of Johannesburg to innovative non-invasive treatment Rhenium-SCT®
November 16, 2021
Tags
Beauty
Painless
Health
From
PRLog
OncoBeta initiates international EPIC-Skin study with Rhenium-SCT® for the treatment of Skin Cancer
September 09, 2021
Tags
Germany
Study
Single/session
From
PRLog
Australian Nuclear Science and Technology Organization (ANSTO), the new production partner of OncoBeta® GmbH in Australia
July 13, 2021
Tags
Painless
Beauty
Sydney
From
PRLog
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.